EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-27.47%
Near historical average
Average (9y)
-26.50%
Historical baseline
Range
High:144.35%
Low:-415.28%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -27.47% |
| 2023 | 33.58% |
| 2022 | -34.98% |
| 2021 | 42.66% |
| 2020 | 41.39% |
| 2019 | 47.48% |
| 2018 | -119.89% |
| 2017 | 23.20% |
| 2016 | -415.28% |
| 2015 | 144.35% |